Taylor & Francis Group
Browse
iwbp_a_2015432_sm8594.docx (1.38 MB)

Growth factors in anorexia nervosa: a systematic review and meta-analysis of cross-sectional and longitudinal data

Download (1.38 MB)
Version 2 2022-01-19, 12:00
Version 1 2021-12-08, 10:00
journal contribution
posted on 2022-01-19, 12:00 authored by Johanna Louise Keeler, Lauren Robinson, Rosemarie Keeler-Schäffeler, Bethan Dalton, Janet Treasure, Hubertus Himmerich

Growth factors are signalling molecules that play roles in the survival, proliferation, migration, and differentiation of cells. Studies have found alterations in specific growth factors in anorexia nervosa (AN).

This systematic review and meta-analysis examined articles from three databases, measuring growth factors in AN cross-sectionally and longitudinally, and in recovered AN (rec-AN) cross-sectionally. Random-effects meta-analyses were conducted for brain-derived neurotrophic factor (BDNF) and insulin growth factor-I (IGF-1) for cross-sectional and longitudinal studies.

A total of 82 studies were included: 56 cross-sectional (BDNF: n = 15; IGF-1: n = 41) and 24 longitudinal (BDNF: n = 5; IGF-1: n = 19) were meta-analysed and 20 studies were narratively synthesised. In cross-sectional analyses, BDNF and IGF-1 were lower in AN compared to controls, and BDNF was marginally greater in rec-AN compared to controls. In longitudinal meta-analyses, BDNF and IGF-1 increased from baseline to follow-up. Cross-sectional subgroup analyses revealed no differences in BDNF between controls and AN binge-eating/purging subtypes.

It is likely that the low BDNF and IGF-1 levels found in AN are consequences of starvation, which are reversible with weight restoration. The increase in BDNF and IGF-1 during therapeutic weight restoration might improve neuroplasticity, which is the basis of learning, and thus psychotherapeutic success.

Funding

Johanna Keeler received a PhD stipend from the Medical Research Council (reference number: MR/N013700/1). Hubertus Himmerich, Janet Treasure and Lauren Robinson received salary support from the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at the South London and Maudsley NHS Foundation Trust (SLaM) and King's College London. Bethan Dalton was supported by the NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC) (Reference: 17/123/03).

History